open access
Sacubitril/valsartan improved microvascular endothelial function in a young patient with COVID-19-related mild left ventricular dysfunction
Affiliations- Department of Cardiac Diagnostics, Medical University of Gdansk, Gdańsk, Poland
- Translational Medicine Centre, Medical University of Gdansk, Gdańsk, Poland
- 1st Department of Cardiology, Medical University of Gdansk, Gdańsk, Poland
- Department of Hypertension and Diabetology, Medical University, Gdańsk, Poland
open access
Abstract
Abstract
About this articleTitle
Sacubitril/valsartan improved microvascular endothelial function in a young patient with COVID-19-related mild left ventricular dysfunction
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Clinical vignette
Published online
2022-03-02
Page views
108
Article views/downloads
84
DOI
10.33963/KP.a2022.0063
Pubmed
Authors
Marcin Hellmann
Edyta Dąbrowska
Marta Żarczyńska-Buchowiecka
Marzena Romanowska-Kocejko
Krzysztof Narkiewicz
Marcin Gruchała
Maria Dudziak
References (5)- Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020; 41(32): 3038–3044.
- Hellmann M, Tarnawska M, Dudziak M, et al. Reproducibility of flow mediated skin fluorescence to assess microvascular function. Microvasc Res. 2017; 113: 60–64.
- Volpe M, Rubattu S, Battistoni A. ARNi: A Novel Approach to Counteract Cardiovascular Diseases. Int J Mol Sci. 2019; 20(9).
- Varga Z, Flammer A, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020; 395(10234): 1417–1418.
- Gori M, D'Elia E, Senni M. Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectives. Int J Cardiol. 2019; 281: 158–165.
